Medicare overpayments could cost Amedisys upwards of $38.8M

    Baton Rouge-based Amedisys is facing a potential loss ranging from $6.5 million to $38.8 million due to alleged Medicare overpayments in Florida, the company announced today in SEC filings. Palmet…

    Already an INSIDER? Sign in.

    We are glad you enjoy reading Business Report.

    Continue reading this story and get ACCESS to all our content from any device with a subscription now.

    • Get access to more than a decade of story archives.
    • Get access to our searchable data center of TOP LISTS.
    • Get exclusive content only available to INSIDERS.